These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33921783)

  • 1. Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts.
    Uruski P; Mikuła-Pietrasik J; Pakuła M; Budkiewicz S; Drzewiecki M; Gaiday AN; Wierzowiecka M; Naumowicz E; Moszyński R; Tykarski A; Książek K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascites microenvironment conditions the peritoneal pre-metastatic niche to promote the implantation of ovarian tumor spheroids: Involvement of fibrinogen/fibrin and αV and α5β1 integrins.
    Laurent-Issartel C; Landras A; Agniel R; Giffard F; Blanc-Fournier C; Da Silva Cruz E; Habes C; Leroy-Dudal J; Carreiras F; Kellouche S
    Exp Cell Res; 2024 Aug; 441(1):114155. PubMed ID: 39002689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
    Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of carboplatin- and paclitaxel-dependent induction of premature senescence and pro-cancerogenic conversion of normal peritoneal mesothelium and fibroblasts.
    Rutecki S; Pakuła-Iwańska M; Leśniewska-Bocianowska A; Matuszewska J; Rychlewski D; Uruski P; Stryczyński Ł; Naumowicz E; Szubert S; Tykarski A; Mikuła-Pietrasik J; Książek K
    J Pathol; 2024 Feb; 262(2):198-211. PubMed ID: 37941520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion.
    Estermann M; Huang YL; Septiadi D; Ritz D; Liang CY; Jacob F; Drasler B; Petri-Fink A; Heinzelmann-Schwarz V; Rothen-Rutishauser B
    PLoS One; 2020; 15(12):e0241500. PubMed ID: 33270665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.
    Cannistra SA; Kansas GS; Niloff J; DeFranzo B; Kim Y; Ottensmeier C
    Cancer Res; 1993 Aug; 53(16):3830-8. PubMed ID: 8339295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells.
    Pakuła M; Witucka A; Uruski P; Radziemski A; Moszyński R; Szpurek D; Maksin K; Woźniak A; Sajdak S; Tykarski A; Mikuła-Pietrasik J; Książek K
    Sci Rep; 2019 May; 9(1):7587. PubMed ID: 31110245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria-related oxidative stress contributes to ovarian cancer-promoting activity of mesothelial cells subjected to malignant ascites.
    Pakuła M; Mikuła-Pietrasik J; Stryczyński Ł; Uruski P; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Int J Biochem Cell Biol; 2018 May; 98():82-88. PubMed ID: 29550585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling.
    Terri M; Sandoval P; Bontempi G; Montaldo C; Tomero-Sanz H; de Turris V; Trionfetti F; Pascual-Antón L; Clares-Pedrero I; Battistelli C; Valente S; Zwergel C; Mai A; Rosanò L; Del Pozo MÁ; Sánchez-Álvarez M; Cabañas C; Tripodi M; López-Cabrera M; Strippoli R
    J Exp Clin Cancer Res; 2024 Jan; 43(1):27. PubMed ID: 38254102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.
    Yokoi A; Yoshioka Y; Yamamoto Y; Ishikawa M; Ikeda SI; Kato T; Kiyono T; Takeshita F; Kajiyama H; Kikkawa F; Ochiya T
    Nat Commun; 2017 Mar; 8():14470. PubMed ID: 28262727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells.
    Wei M; Yang T; Chen X; Wu Y; Deng X; He W; Yang J; Wang Z
    Oncotarget; 2017 Jun; 8(26):42262-42271. PubMed ID: 28178689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources.
    Zhang XY; Pettengell R; Nasiri N; Kalia V; Dalgleish AG; Barton DP
    J Soc Gynecol Investig; 1999; 6(6):333-40. PubMed ID: 10643588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin.
    Ksiazek K; Mikula-Pietrasik J; Korybalska K; Dworacki G; Jörres A; Witowski J
    Am J Pathol; 2009 Apr; 174(4):1230-40. PubMed ID: 19246646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell‑fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer.
    Han Q; Huang B; Huang Z; Cai J; Gong L; Zhang Y; Jiang J; Dong W; Wang Z
    Int J Mol Med; 2019 Dec; 44(6):2245-2255. PubMed ID: 31638162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.
    Desjardins M; Xie J; Gurler H; Muralidhar GG; Sacks JD; Burdette JE; Barbolina MV
    J Ovarian Res; 2014; 7():70. PubMed ID: 24999371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
    Matte I; Garde-Granger P; Bessette P; Piché A
    BMC Cancer; 2019 Apr; 19(1):406. PubMed ID: 31039761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel strategy of ovarian cancer implantation: Pre-invasive growth of fibrin-anchored cells with neovascularization.
    Matsuoka A; Mizumoto Y; Ono M; Kagami K; Obata T; Terakawa J; Maida Y; Nakamura M; Daikoku T; Fujiwara H
    Cancer Sci; 2019 Aug; 110(8):2658-2666. PubMed ID: 31199029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
    Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
    Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal mesothelium promotes the progression of ovarian cancer cells in vitro and in a mice xenograft model in vivo.
    Mikuła-Pietrasik J; Sosińska P; Kucińska M; Murias M; Maksin K; Malińska A; Ziółkowska A; Piotrowska H; Woźniak A; Książek K
    Cancer Lett; 2014 Dec; 355(2):310-5. PubMed ID: 25301450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
    Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
    J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.